LeadStory

Reuters

Vaccine for fatal elephant virus ready for wider use, researchers say

Reuters · Just In
Reuters
Reuters
Just In

A vaccine against elephant endotheliotropic herpesvirus (EEHV), a disease that can kill young elephants within 24 hours of symptoms, is ready for wider use, researchers announced on Friday (October 3).

Breakdown
  • A vaccine for the fatal elephant virus EEHV is ready for wider use after successful trials. 6s
  • EEHV can cause deadly hemorrhagic disease in young elephants and has been reported in Asia and conservation programs. 18s
  • Proof-of-concept trials showed the vaccine is safe and triggers strong immune responses. 40s
  • The vaccine was first tested on adult elephants, but the focus is now on protecting calves with weaker immune systems. 1m 20s
  • Researchers are working on expanding vaccine delivery and prioritizing at-risk calves. 1m 54s
Pets & AnimalsHealth